This move is archived. Current quotes and coverage live on the stock page.
Follow WAVE
Waverley Pharma Inc experienced a remarkable surge in stock price, gaining over 33% in yesterday's trading session.
Waverley Pharma Inc (WAVE.V) saw its stock price climb by an impressive 33.33% in yesterday's session, closing at CA$0.02. This notable increase has drawn attention to the biopharmaceutical company, which focuses on oncology therapeutics and operates a retail pharmacy in the U.S.
Waverley Pharma Inc
WAVE.V
WAVE.V
Waverley Pharma Inc
WealthAwesomeMarket cap
$540,000
52W high
$0.03
52W low
$0.01
1W change
+100.00%
Beta
1.46
Analyst Price Targets
Based on analyst covering WAVE · as of Sep 17, 2026
Wall Street analysts forecast WAVE stock price to rise 49900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$10.00
+49900.0% Upside
Current Price
C$0.02
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WAVE's historical volatility
30-Day Vol
518.1%
Annualized
90-Day Vol
520.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.00 – C$0.13 |
| 60 trading days | C$0.02 | C$0.00 – C$0.28 |
| 90 trading days | C$0.02 | C$0.00 – C$0.53 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may want to keep an eye on Waverley Pharma, especially in light of its recent acquisition of a U.S.-based pharmacy, which could enhance its market presence and revenue potential.
Waverley Pharma Inc stock jumped 33.33% yesterday
The stock's increase brought its market capitalization to approximately CA$810,000, highlighting its small-cap status and the volatility often associated with such companies.
Bull case
The acquisition of C&R Pharmacy LLC could lead to new revenue streams and a stronger foothold in the U.S. pharmacy market. This move positions Waverley Pharma for potential growth and greater market influence.
Bear case
Despite the recent surge, Waverley Pharma's financials show ongoing challenges, including a negative profit margin. This raises concerns about the company's long-term viability and stability in the market.
Recent Performance
Waverley Pharma's stock performance yesterday marked a significant uptick, with a closing price of CA$0.02. This increase is noteworthy for a company with a market cap of CA$810,000, indicating heightened investor interest and potential market activity.
Strategic Acquisition
The recent acquisition of C&R Pharmacy LLC for US$450,000 may have contributed to the stock's surge. This move could enhance Waverley Pharma's operational capabilities and revenue potential, particularly in the U.S. market.
Financial Outlook
While the stock saw a positive move, Waverley Pharma's financial health remains a concern. The company reported a profit margin of -0.5047, suggesting ongoing challenges that investors should consider when evaluating the stock's long-term prospects.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
